US 8933249
3-(phenoxyphenylmethyl)pyrrolidine compounds
granted A61KA61K31/40A61P
Quick answer
US patent 8933249 (3-(phenoxyphenylmethyl)pyrrolidine compounds) held by Theravance Biopharma R&D IP, LLC expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/40, A61P, A61P13/10, A61P15/12